drugset
Drugs / Bacillus Calmette-Guérin
last change Jan 2026 re-read 3 minutes ago

Bacillus Calmette-Guérin

also known as BCG · Tokyo 172

Vaccine

Developed for
tuberculosis
Investigated by
Henry M. Jackson Foundation for the Advancement of Military Medicine · Uniformed Services University of the Health Sciences · United States Department of Defense

Trials 1

today NCT04453293 · Ph 3
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04453293 Dec 2021 → Jan 2026 tuberculosis Henry M. Jackson Foundation for the Advancement of Military Medicine Terminated No outcome recorded Stop: Enrollment

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bacillus Calmette-Guérin “Freeze-Dried Glutamate Bacillus Calmette-Guérin BCG Vaccine (Japan BCG Laboratory)” NCT04453293 ↗
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT04453293 ↗
Known as Tokyo 172 “BCG (Tokyo 172) vaccine” NCT04453293 ↗
Modality Vaccine “Freeze-dried Glutamate Bacillus Calmette-Guérin (BCG) (Tokyo 172) vaccine” NCT04453293 ↗